Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Target therapy of multiple myeloma by PTX-NPs and ABCG2 antibody in a mouse xenograft model.

Oncotarget - 29 Sept 2015

Yang Cuiping, Xiong Fei, Dou Jun, Xue Jun, Zhan Xi, Shi Fangfang, Li Miao, Wu Songyan, Luo Shouhua, Zhang Tianzhu, Zhang Yu, Ming Ji, Gu Ning

Abstract excerpt

Multiple myeloma (MM) remains to be an incurable disease. The purpose of this study was to evaluate the effect of ABCG2 monoclonal antibody (McAb) combined with paclitaxel (PTX) conjugated with Fe3O4 nanoparticles (NPs) on MM progressed from cancer stem cells (CSCs) in non-obese-diabetic/severe-c...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to ATP Binding Cassette Transporter, Subfamily G, Member 2
Share to Drug Carriers
Share to Melphalan

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Metal Nanoparticles

Share to Paclitaxel

Share to Prednisone

Share to Syndecan-1

Share to X-Ray Microtomography

Source

Open in PubMed Open full text

Identifiers

PMID: 26314844
DOI: 10.18632/oncotarget.4663
PMCID: PMC4695020

Genes

ABCG2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-26314844-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Target therapy of multiple myeloma by PTX-NPs and ABCG2 antibody in a mouse xenograft model.PMID 26314844Read ↗

Inhibitory effect of epirubicin-loaded lipid microbubbles with conjugated anti-ABCG2 antibody combined with therapeutic ultrasound on multiple myeloma cancer stem cells.Semantic proximity Read ↗

Multiple Myeloma: Challenges Encountered and Future Options for Better Treatment.Semantic proximity Read ↗

Targeted therapy of multiple myeloma: the changing paradigm at the beginning of the new millennium.Semantic proximity Read ↗

Adoptive Cellular Therapy for Multiple Myeloma Using CAR- and TCR-Transgenic T Cells: Response and ResistanceSemantic proximity Read ↗

Correlation analysis of circulating myeloma cells with tumor load, angiogenesis and disease progression of multiple myeloma and clinical significanceSemantic proximity Read ↗

Design of a novel NanoCAR construct that compares well with a conventional ScFv-based CAR targeting BCMA on multiple myelomaSemantic proximity Read ↗

Targeting of multiple myeloma-related angiogenesis by miR-199a-5p mimics: in vitro and in vivo anti-tumor activitySemantic proximity Read ↗

Extracellular Vesicles Enhance Multiple Myeloma Metastatic DisseminationSemantic proximity Read ↗

CXCL7 plays a crucial role in facilitating extramedullary invasion and osteolytic damage in multiple myelomaSemantic proximity Read ↗

Identification of potential biomarkers or therapeutic targets of mesenchymal stem cells in multiple myeloma by bioinformatics analysisSemantic proximity Read ↗

Paeoniflorin inhibiting the angiogenesis via decreasing MEF2A level to downregulate the expression of LncRNA MALAT1 of exosomes in multiple myelomaSemantic proximity Read ↗

NRF2 Is One of the Players Involved in Bone Marrow Mediated Drug Resistance in Multiple MyelomaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.